About Enhancer
| Enhancer ID: | E_00776 |
| Species: | Mus musculus |
| Position : | chr4:115040426-115042426   |
| Year: | 2016 |
| Title: | Integrated genome-scale analysis of the transcriptional regulatory landscape in a blood stem/progenitor cell model. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 26809507 |
| Cell Source: | HPC-7 |
| CVCL ID: | CVCL_RB19 |
| Experiment Type: | TF-binding/chromatin assay; Chromatin interaction assay; In vivo functional validation |
| High Throughput Method: | ChIP-seq; Hi-C |
| Low Throughput Method: | ChIP-qPCR/ChIP; Transgenic/LacZ assay |
About Target Gene
| Target gene : | Tal1 |
About TF
| TF name : | Cebpa |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Cebpa | AndrogenReceptor | netpath | 167 |
| Cebpa | C-MYB transcription factor network | pid | 87 |
| Cebpa | E2F transcription factor network | pid | 77 |
| Cebpa | EGFR1 | netpath | 475 |
| Cebpa | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
| Cebpa | IL4 | netpath | 75 |
| Cebpa | Regulation of Androgen receptor activity | pid | 54 |
| Cebpa | Regulation of retinoblastoma protein | pid | 67 |
| Cebpa | Transcriptional regulation of white adipocyte differentiation | reactome | 79 |
| Cebpa | Validated targets of C-MYC transcriptional repression | pid | 63 |
| Cebpa | Pathways in cancer | kegg | 321 |
| Cebpa | Acute myeloid leukemia | kegg | 53 |
| Cebpa | Hs_Regulation_of_Actin_Cytoskeleton_WP51_79977 | wikipathways | 36 |
| Cebpa | Hs_Pathways_Affected_in_Adenoid_Cystic_Carcinoma_WP3651_89271 | wikipathways | 27 |
| Cebpa | Hs_Nucleotide_Metabolism_WP404_68960 | wikipathways | 16 |
| Cebpa | Hs_Transcription_factor_regulation_in_adipogenesis_WP3599_88581 | wikipathways | 9 |
Enhancer Associated Network
Overlapping Enhancers (mm10)
15 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00775 | chr4:115040426-115042426 | NA | NA | NA |
| E_00777 | chr4:115040426-115042426 | NA | NA | NA |
| E_00778 | chr4:115040426-115042426 | NA | NA | NA |
| E_00779 | chr4:115040426-115042426 | NA | NA | NA |
| E_00780 | chr4:115040426-115042426 | NA | NA | NA |
| E_00781 | chr4:115040426-115042426 | NA | NA | NA |
| E_00782 | chr4:115040426-115042426 | NA | NA | NA |
| E_00783 | chr4:115040426-115042426 | NA | NA | NA |
| E_00784 | chr4:115040426-115042426 | NA | NA | NA |
| E_00785 | chr4:115040426-115042426 | NA | NA | NA |
| E_00786 | chr4:115040426-115042426 | NA | NA | NA |
| E_00787 | chr4:115040426-115042426 | NA | NA | NA |
| E_00788 | chr4:115040426-115042426 | NA | NA | NA |
| E_00789 | chr4:115040426-115042426 | NA | NA | NA |
| E_00790 | chr4:115040426-115042426 | NA | NA | NA |
Expression of Target Genes for the Enhancer